Related Experiment Videos
Lower airways inflammatory response during rhinovirus colds
P G Bardin1, D J Fraenkel, G Sanderson
1Southampton General Hospital, UK.
International Archives of Allergy and Immunology
|May 1, 1995
Summary
Human rhinovirus (HRV) infections increase airway hyperresponsiveness. HRV colds are linked to increased lymphocytes and eosinophils in the bronchial mucosa, potentially explaining asthma exacerbations.
Area of Science:
- Immunology
- Respiratory Medicine
- Virology
Background:
- Human rhinovirus (HRV) is a primary cause of the common cold.
- The mechanisms linking viral infections to altered airway reactivity, particularly in asthma exacerbations, remain unclear.
- Changes in endobronchial cell populations are hypothesized to play a role.
Purpose of the Study:
- To investigate the association between experimental human rhinovirus infections and changes in airway reactivity.
- To examine the cellular infiltrate in the bronchial mucosa during HRV infection.
- To explore the potential link between these cellular changes and asthma exacerbations.
Main Methods:
- 17 adult volunteers, including 6 atopic asthmatics, underwent experimental HRV serotype 16 infection.
- Bronchial mucosal biopsies were collected before, during, and after infection.
- Immunohistochemical techniques were used to quantify mast cells, eosinophils, lymphocytes, and neutrophils.
- Histamine reactivity (PC20) was measured to assess airway responsiveness.
Main Results:
- A significant increase in histamine responsiveness (PC20) was observed during HRV infection (p = 0.048).
- Submucosal lymphocyte counts increased significantly (p = 0.05).
- Epithelial eosinophil counts significantly increased with infection (p = 0.042), persisting in asthmatics post-infection.
Conclusions:
- Rhinoviral common colds are associated with increased airway hyperresponsiveness.
- A lymphocytic and eosinophilic infiltrate in the bronchial mucosa accompanies HRV infection.
- These mucosal changes may contribute to altered airway responsiveness and asthma exacerbations.